Kadima Neuropsychiatry Institute
Kadima Neuropsychiatry Institute
La Jolla, California, United States11 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response | Depressive Disorder, Treatment-Resistant, depressive disorder, major depressive disorder, mood disorder, psychiatric disorder | Recruiting | Phase 2 | 2026-10-05 | NCT07284667 | |
| "A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder" | depressive disorder, major depressive disorder, mood disorder, psychiatric disorder | Active, not recruiting | Phase 3 | 2026-09-28 | NCT06564818 | |
| A Phase 3 Trial of DT120 for Generalized Anxiety Disorder (Voyage) | anxiety disorder, generalized anxiety disorder, psychiatric disorder | Active, not recruiting | Phase 3 | 2026-09-25 | NCT06741228 | |
| Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND) | depressive disorder, major depressive disorder, mood disorder, psychiatric disorder | Enrolling by invitation | Phase 3 | 2026-09-25 | NCT06605105 | |
| RE104 Safety and Efficacy Study in Generalized Anxiety Disorder | anxiety disorder, generalized anxiety disorder, psychiatric disorder | Recruiting | Phase 2 | 2026-09-24 | NCT07489651 | |
| A Phase 3 Trial of DT120 for Major Depressive Disorder (Emerge) | depressive disorder, major depressive disorder, mood disorder, psychiatric disorder | Active, not recruiting | Phase 3 | 2026-08-28 | NCT06941844 | |
| Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD | Depressive Disorder, Treatment-Resistant, depressive disorder, mood disorder, psychiatric disorder | Active, not recruiting | Phase 3 | 2026-08-10 | NCT05711940 | |
| Psilocybin for Major Depressive Disorder (MDD) | depressive disorder, major depressive disorder, mood disorder, psychiatric disorder | Active, not recruiting | Phase 3 | 2026-07-23 | NCT06308653 | |
| A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA) | Depressive Disorder, Treatment-Resistant, depressive disorder, major depressive disorder, mood disorder, psychiatric disorder | Recruiting | Phase 2 | 2026-05-11 | NCT06524830 | |
| Prediction of REsponse to Depression Interventions Using Clinical and TD-fNIRS Measurements | depressive disorder, major depressive disorder, mood disorder, psychiatric disorder | Enrolling by invitation | Not stated | 2025-12-12 | NCT06002100 | |
| A Phase II, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of COMP360 in Participants With Recurrent Major Depressive Disorder | depressive disorder, major depressive disorder, mood disorder, psychiatric disorder | Active, not recruiting | Phase 2 | 2025-08-19 | NCT05733546 |